{{DISPLAYTITLE:Technetium (<sup>99m</sup>Tc) votumumab}}
{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 470478400
| image =  
| drug_name = Technetium (<sup>99m</sup>Tc) votumumab
<!-- Monoclonal antibody data -->
| type = mab
| mab_type = mab
| source = u
| target = [[tumor antigen]] CTAA16.88
<!-- Clinical data -->
| tradename =  
| pregnancy_AU =  
| pregnancy_US =  
| pregnancy_category =  
| legal_AU =  
| legal_CA =  
| legal_UK =  
| legal_US =  
| legal_status = not marketed
| routes_of_administration =  
<!-- Pharmacokinetic data -->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  
<!-- Identifiers -->
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = none
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 148189-70-2
| ATC_prefix = V09
| ATC_suffix = IA04
| ATC_supplemental =  
| PubChem =  
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
<!-- Chemical data -->
| chemical_formula =  
| molecular_weight =  
}}

'''Technetium (<sup>99m</sup>Tc) votumumab''' (trade name '''HumaSPECT''') is a human [[monoclonal antibody]] labelled with the [[radionuclide]] [[technetium-99m]].<ref>[http://whqlibdoc.who.int/druginfo/INN_1999_list41.pdf WHO Drug Information]</ref> It was developed for the detection of [[colorectal]] [[tumor]]s, but has never been marketed.<ref name="EMEA">[http://www.emea.europa.eu/pdfs/human/press/pus/388504en.pdf EMA: Public Statement on HumaSPECT]</ref>

The target of votumumab is CTAA16.88, a complex of [[cytokeratin]] polypeptides in the molecular weight range of 35 to 43 [[kDa]], which is expressed in colorectal tumors.<ref>[http://ec.europa.eu/enterprise/sectors/pharmaceuticals/documents/community-register/1998/199809253252/anx_3252_en.pdf EMA: Summary of Product Characteristics for HumaSPECT]</ref>

==References==
{{reflist}}

{{Radiopharmaceuticals}}
{{Monoclonals for tumors}}

[[Category:Radiopharmaceuticals]]
[[Category:Experimental cancer drugs]]
[[Category:Technetium-99m]]


{{monoclonal-antibody-stub}}
{{antineoplastic-drug-stub}}